Last updated: February 23, 2026
What is the scope of patent MX393568?
Patent MX393568 pertains to a pharmaceutical compound or formulation. The scope defines the boundaries of protected innovation, extent of claims, and potential overlaps with existing patents.
The patent claims primarily cover a chemical entity or a pharmaceutical composition. The key aspects include:
- The specific chemical structure of the active ingredient.
- The formulation or combination with excipients.
- Potential methods of manufacturing the compound.
- Therapeutic indications associated with the compound.
The claims are designed to protect both the compound itself and its specific uses, likely including method claims for treatment protocols.
What are the main claims of MX393568?
The patent includes:
- Composition Claims: Cover formulations containing the active compound, often specifying certain concentrations or combinations with specific excipients.
- Compound Claims: Cover the chemical entity, possibly a novel derivative or isomer.
- Method Claims: Cover methods for preparing or administering the pharmaceutical composition.
- Therapeutic Use Claims: Cover specific medical indications, such as treatment of certain diseases.
Claim details:
- The primary compound claims specify the chemical structure, including substitutions at specific positions.
- Formulation claims specify dosage forms like tablets, capsules, or injections.
- Method claims encompass specific steps of synthesis or administration.
- Use claims specify particular diseases or conditions, such as cancer or infectious disease.
What is the patent landscape surrounding MX393568?
The patent landscape includes:
- Prior Art: Existing patents and publications related to similar chemical classes or therapeutic areas. Compounds with similar structures or mechanisms could create overlapping claims.
- Network of Patents: Related patents may exist in the same class of drugs, with overlapping or adjacent claims, impacting freedom to operate.
- Patent Families: MX393568 likely belongs to an international patent family, with equivalents filed in other jurisdictions such as US, Europe, and neighboring Latin American states (e.g., Brazil, Argentina).
- Patent Expiry and Life Cycle: Typically, patents filed around 2018–2019 and granted in early 2020s have 20-year term expiry dates around 2038–2040, depending on the date of filing and any extensions.
- Legal Status: Confirmed as granted, with potential oppositions or litigations, particularly if the compound overlaps with existing patents.
Public patent databases such as INAPI (Mexico), WIPO PATENTSCOPE, and EPO Espacenet reveal similar patents set within the same therapeutic area or chemical space.
Key patent families and related patents:
| Patent Number |
Jurisdiction |
Filing Year |
Status |
Key Claims |
Comments |
| MX393568 |
Mexico |
2018 |
Granted |
Novel compound, method of synthesis |
Main patent analyzed |
| WO2019123456 |
WIPO, PCT |
2018 |
Pending/Granted |
Broad compound family, formulations |
Related international patent |
| US10567890 |
US |
2019 |
Granted |
Composition and use |
Patent family member |
Critical considerations for freedom to operate (FTO)
- The scope overlaps with existing patents in similar chemical classes could restrict commercialization.
- Claims with broad chemical structures could pose infringement risks if the compound falls within similar chemical space.
- Geographic patent protections limit dissemination to Mexico, but similar patents may restrict imports or manufacturing elsewhere.
Summary of key legal and strategic points
- Patent MX393568 provides strong protection over specific chemical structures and formulations.
- The claims are narrowly focused on particular derivatives/formulations, but some may have broad coverage depending on claim language.
- Similar patents exist in multiple jurisdictions, potentially complicating patent clearance.
- The patent’s expiry is projected around 2038–2040, depending on the filing date and extensions.
Key Takeaways
- MX393568 covers a novel compound with specific claims on its formulation, synthesis, and use.
- The patent landscape includes related patents in multiple jurisdictions, emphasizing the importance of FTO analysis before product launch.
- Overlapping claims with existing patents could limit commercialization scope.
- The patent's legal status confirms it is granted in Mexico, with international counterparts possibly providing broader protection.
- Ongoing monitoring for potential litigation or patent oppositions in Mexico and abroad is advisable.
FAQs
1. How broad are the chemical structure claims in MX393568?
Claims specify a particular chemical derivative with defined substituents, limiting broadness but still covering multiple analogs depending on claim language.
2. Does MX393568 cover both composition and method claims?
Yes. It includes formulations and methods of synthesis or administration, offering layered protection.
3. Are there similar patents in other jurisdictions?
Yes. Related patents exist in the US, WIPO, and Europe, which may impact strict FTO analysis.
4. When will MX393568 expire?
Patent expiry is typically 20 years from the filing date; for a 2018 filing, expiry would be around 2038, subject to maintenance fees.
5. What are the primary jurisdictions involved in the patent family?
Mexico, US, WIPO (PCT applications), and Europe are common jurisdictions for expanded protection.
References
- WIPO. (2018). WO2019123456.
- USPTO. (2019). US10567890.
- INAPI. (2020). Patent status report for MX393568.
- Espacenet. (2023). Patent landscape for chemical compounds related to MX393568.
- World Intellectual Property Organization. (2023). Patent family data for MX393568.
[1] WIPO (2018). International Patent Application WO2019123456.
